Besivance and Cough - a phase IV clinical study of FDA data

Summary:

Cough is reported as a side effect among people who take Besivance (besifloxacin hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Durezol, and have Conjunctivitis bacterial.

The phase IV clinical study analyzes which people have Cough when taking Besivance. It is created by eHealthMe based on reports of 1,097 people who have side effects when taking Besivance from the FDA, and is updated regularly.

What is Besivance?

Besivance has active ingredients of besifloxacin hydrochloride. eHealthMe is studying from 1,102 Besivance users. Check the latest studies of Besivance.

What is Cough?

Cough is found to be associated with 3,055 drugs and 3,800 conditions by eHealthMe. Check the latest studies of Cough.

On Jul, 13, 2026

1,097 people reported to have side effects when taking Besivance.
Among them, 12 people (1.09%) have Cough.

Among these 12 people:

How long have people been on Besivance when they have Cough? *

What is the gender of people who have Cough when taking Besivance? *

female: 75 %
male: 25 %

What is the age of people who have Cough when taking Besivance? *

What are other drugs people take besides Besivance? *

What are other side effects people have besides Cough? *

Fatigue (feeling of tiredness): 4 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Eye Discharge: 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Weight Increased: 1 person, 8.33%
General Symptom: 1 person, 8.33%
Fever: 1 person, 8.33%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 8.33%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Conjunctivitis Bacterial (infection of conjunctiva by bacteria): 2 people, 16.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 8.33%
Immunodeficiency Common Variable: 1 person, 8.33%
Asthma: 1 person, 8.33%
Blood Glucose Abnormal: 1 person, 8.33%
Cardiac Murmur (an heart sound in valve abnormality): 1 person, 8.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 8.33%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Besivance and have Cough?

- Check whether Cough is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Besivance:

Besivance (1,102 reports)

Cough treatments and more:

Cough (361,791 reports)

Browse all side effects of Besivance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cough:

Cough (3,055 drugs)

Browse all the conditions that are associated with Cough:

Cough (3,800 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on besifloxacin hydrochloride (the active ingredients of Besivance) and Besivance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.